{"id": "article-129466_0", "title": "Lipoid Proteinosis -- Continuing Education Activity", "content": "Lipoid proteinosis is an autosomal recessive condition characterized by hyaline-like deposits in the skin, mucous membranes, and other parts of the body. It is caused by a mutation in the extracellular matrix 1 (ECM1) gene. This activity reviews the evaluation and management of lipoid proteinosis and highlights the role of the interprofessional team in improving care for patients with this condition.", "contents": "Lipoid Proteinosis -- Continuing Education Activity. Lipoid proteinosis is an autosomal recessive condition characterized by hyaline-like deposits in the skin, mucous membranes, and other parts of the body. It is caused by a mutation in the extracellular matrix 1 (ECM1) gene. This activity reviews the evaluation and management of lipoid proteinosis and highlights the role of the interprofessional team in improving care for patients with this condition."}
{"id": "article-129466_1", "title": "Lipoid Proteinosis -- Continuing Education Activity", "content": "Objectives: Summarize the etiology of lipoid proteinosis. Describe the most common physical exam findings in patients with lipoid proteinosis. Outline the epidemiology of lipoid proteinosis. Review some interprofessional team strategies that the healthcare team can use to improve outcomes in patients with lipoid proteinosis. Access free multiple choice questions on this topic.", "contents": "Lipoid Proteinosis -- Continuing Education Activity. Objectives: Summarize the etiology of lipoid proteinosis. Describe the most common physical exam findings in patients with lipoid proteinosis. Outline the epidemiology of lipoid proteinosis. Review some interprofessional team strategies that the healthcare team can use to improve outcomes in patients with lipoid proteinosis. Access free multiple choice questions on this topic."}
{"id": "article-129466_2", "title": "Lipoid Proteinosis -- Introduction", "content": "Urbach and Wiethe first described lipoid Proteinosis (LP) (hyalinosis cutis et mucosae) in 1929. [1] LP is a rare genodermatosis characterized by the deposition of hyaline-like material in various tissues and organs.\u00a0LP is associated with a variety of characteristic cutaneous and mucosal findings and several neurologic, psychiatric, and gastrointestinal manifestations. [2] [3] [4] [5] [6]", "contents": "Lipoid Proteinosis -- Introduction. Urbach and Wiethe first described lipoid Proteinosis (LP) (hyalinosis cutis et mucosae) in 1929. [1] LP is a rare genodermatosis characterized by the deposition of hyaline-like material in various tissues and organs.\u00a0LP is associated with a variety of characteristic cutaneous and mucosal findings and several neurologic, psychiatric, and gastrointestinal manifestations. [2] [3] [4] [5] [6]"}
{"id": "article-129466_3", "title": "Lipoid Proteinosis -- Etiology", "content": "LP is caused by a homozygous or compound heterozygous loss-of-function mutation in the extracellular matrix protein 1 (ECM1) gene located on chromosome 1q21. [7] [8] [9] Most ECM1 mutations are frameshift or nonsense mutations in exons 6 or 7, resulting in a truncated ECM1. [8] The ECM1 gene encodes glycoproteins essential for basement membrane and extracellular matrix structure integrity, skin adhesion, and protein-protein interactions. [9] [10] Since there are various ECM1 splice variants and mutations, many LP genotypes and phenotypes are possible. [8] [10] LP is inherited in an autosomal recessive pattern. Patients often have affected family members, and some are children of consanguineous parents.", "contents": "Lipoid Proteinosis -- Etiology. LP is caused by a homozygous or compound heterozygous loss-of-function mutation in the extracellular matrix protein 1 (ECM1) gene located on chromosome 1q21. [7] [8] [9] Most ECM1 mutations are frameshift or nonsense mutations in exons 6 or 7, resulting in a truncated ECM1. [8] The ECM1 gene encodes glycoproteins essential for basement membrane and extracellular matrix structure integrity, skin adhesion, and protein-protein interactions. [9] [10] Since there are various ECM1 splice variants and mutations, many LP genotypes and phenotypes are possible. [8] [10] LP is inherited in an autosomal recessive pattern. Patients often have affected family members, and some are children of consanguineous parents."}
{"id": "article-129466_4", "title": "Lipoid Proteinosis -- Epidemiology", "content": "LP occurs worldwide but is rare, with only about 400 cases reported in the medical literature. [10] [11] [12] Males and females are affected equally. [9] The Namaqualand region in South Africa has the largest LP patients sharing a common mutation, suggesting a founder effect. [12] There is a higher incidence of LP in countries where consanguinity is more common. [13] [14]", "contents": "Lipoid Proteinosis -- Epidemiology. LP occurs worldwide but is rare, with only about 400 cases reported in the medical literature. [10] [11] [12] Males and females are affected equally. [9] The Namaqualand region in South Africa has the largest LP patients sharing a common mutation, suggesting a founder effect. [12] There is a higher incidence of LP in countries where consanguinity is more common. [13] [14]"}
{"id": "article-129466_5", "title": "Lipoid Proteinosis -- Pathophysiology", "content": "ECM1 is a glycoprotein that plays various extracutaneous roles, including regulation of endochondral bone and cartilage formation,\u00a0endothelial cell proliferation and angiogenesis,\u00a0and dendritic cell differentiation. [15] High levels of ECM1 expression may be associated with certain malignancies. [16] [17]", "contents": "Lipoid Proteinosis -- Pathophysiology. ECM1 is a glycoprotein that plays various extracutaneous roles, including regulation of endochondral bone and cartilage formation,\u00a0endothelial cell proliferation and angiogenesis,\u00a0and dendritic cell differentiation. [15] High levels of ECM1 expression may be associated with certain malignancies. [16] [17]"}
{"id": "article-129466_6", "title": "Lipoid Proteinosis -- Pathophysiology", "content": "In the skin, ECM1 interacts with basement membrane-specific heparan sulfate proteoglycan core protein (HSPG), also known as perlecan, and other proteins important for ECM structure and tissue remodeling like matrix metalloproteinase-9, fibulin-3, and laminin 332. [10] [18] [19] Certain ECM1 splice variants are expressed within basal keratinocytes and suprabasal cells, indicating a possible role in keratinocyte differentiation. [20] ECM1 expression is reduced in individuals with chronic ultraviolet light exposure, suggesting an additional role in the cutaneous stress response. [21] Ultrastructural analysis of erosive lesions in a child revealed \u201cfree-floating\u201d desmosomes as well as connection loss between some desmosomes and the keratin filament network. This points to a possible role for ECM1 in the attachment between keratin filaments and the desmosome. [22]", "contents": "Lipoid Proteinosis -- Pathophysiology. In the skin, ECM1 interacts with basement membrane-specific heparan sulfate proteoglycan core protein (HSPG), also known as perlecan, and other proteins important for ECM structure and tissue remodeling like matrix metalloproteinase-9, fibulin-3, and laminin 332. [10] [18] [19] Certain ECM1 splice variants are expressed within basal keratinocytes and suprabasal cells, indicating a possible role in keratinocyte differentiation. [20] ECM1 expression is reduced in individuals with chronic ultraviolet light exposure, suggesting an additional role in the cutaneous stress response. [21] Ultrastructural analysis of erosive lesions in a child revealed \u201cfree-floating\u201d desmosomes as well as connection loss between some desmosomes and the keratin filament network. This points to a possible role for ECM1 in the attachment between keratin filaments and the desmosome. [22]"}
{"id": "article-129466_7", "title": "Lipoid Proteinosis -- Pathophysiology", "content": "Mutations within the ECM1 gene lead to compromised protein-protein interactions and disrupted tissue homeostasis. [8] [9] [10] Hyaline-like accumulation within different tissues explains many classic clinical findings like hoarseness, moniliform blepharosis, and seizures.", "contents": "Lipoid Proteinosis -- Pathophysiology. Mutations within the ECM1 gene lead to compromised protein-protein interactions and disrupted tissue homeostasis. [8] [9] [10] Hyaline-like accumulation within different tissues explains many classic clinical findings like hoarseness, moniliform blepharosis, and seizures."}
{"id": "article-129466_8", "title": "Lipoid Proteinosis -- Histopathology", "content": "Histologically, LP is characterized by hyaline-like periodic acid-Schiff (PAS)-positive, diastase-resistant deposits within the papillary dermis and at the dermal-epidermal junction (DEJ). [23] [24] The basement membrane surrounding blood vessels at the DEJ is reduplicated and structurally disrupted. [25] [26] Other blood vessel abnormalities include marked dilation and absence of several groups of vessels (including the dermal papillae capillary loop network, the subcutaneous plexus, and the transverse connecting vessels). [24] Additional histopathologic findings include sweat gland hyalinization and hyperkeratosis.", "contents": "Lipoid Proteinosis -- Histopathology. Histologically, LP is characterized by hyaline-like periodic acid-Schiff (PAS)-positive, diastase-resistant deposits within the papillary dermis and at the dermal-epidermal junction (DEJ). [23] [24] The basement membrane surrounding blood vessels at the DEJ is reduplicated and structurally disrupted. [25] [26] Other blood vessel abnormalities include marked dilation and absence of several groups of vessels (including the dermal papillae capillary loop network, the subcutaneous plexus, and the transverse connecting vessels). [24] Additional histopathologic findings include sweat gland hyalinization and hyperkeratosis."}
{"id": "article-129466_9", "title": "Lipoid Proteinosis -- Histopathology", "content": "Immunolabeling can be a useful diagnostic tool, especially early in the disease course. Reduced ECM1 protein in conjunction with characteristic clinical findings should heighten suspicion for LP. [27] Congo-red staining can help differentiate LP from amyloidosis, which is often on the differential diagnosis.", "contents": "Lipoid Proteinosis -- Histopathology. Immunolabeling can be a useful diagnostic tool, especially early in the disease course. Reduced ECM1 protein in conjunction with characteristic clinical findings should heighten suspicion for LP. [27] Congo-red staining can help differentiate LP from amyloidosis, which is often on the differential diagnosis."}
{"id": "article-129466_10", "title": "Lipoid Proteinosis -- History and Physical", "content": "In almost all affected individuals, the earliest manifestation is a weak or hoarse cry in early life due to hyaline-like deposits on the vocal cords. [10] [28] [29] Hoarseness and severe dysphonia (\u201chusky\u201d voice) can develop and persist throughout life. [30] Deposits within the larynx can occasionally obstruct the airway. [31]", "contents": "Lipoid Proteinosis -- History and Physical. In almost all affected individuals, the earliest manifestation is a weak or hoarse cry in early life due to hyaline-like deposits on the vocal cords. [10] [28] [29] Hoarseness and severe dysphonia (\u201chusky\u201d voice) can develop and persist throughout life. [30] Deposits within the larynx can occasionally obstruct the airway. [31]"}
{"id": "article-129466_11", "title": "Lipoid Proteinosis -- History and Physical", "content": "Cutaneous abnormalities also present early in the disease course, usually beginning with vesicles or bullae and hemorrhagic crusts on sites of friction or trauma, most notably the face and around the mouth. [13] These lesions heal with prominent pox-like or acneiform scarring (Figure A). [32] Over time, the skin can appear thick and waxy with a yellowish hue. [29] Moniliform blepharosis, \u201cbeaded\u201d papules along the eyelid margin, is a pathognomonic finding identified in about 50% of patients (Figure B). [33] Other cutaneous manifestations include papules, nodules, plaques on the face and lips, and verrucous and hyperkeratotic lesions at sites of trauma or friction. [29] Early clinical clues, namely cutaneous buttocks lesions, may predict a more severe clinical course with neurologic involvement. [34] There have been infrequent reports of patchy or diffuse alopecia at lesional sites.", "contents": "Lipoid Proteinosis -- History and Physical. Cutaneous abnormalities also present early in the disease course, usually beginning with vesicles or bullae and hemorrhagic crusts on sites of friction or trauma, most notably the face and around the mouth. [13] These lesions heal with prominent pox-like or acneiform scarring (Figure A). [32] Over time, the skin can appear thick and waxy with a yellowish hue. [29] Moniliform blepharosis, \u201cbeaded\u201d papules along the eyelid margin, is a pathognomonic finding identified in about 50% of patients (Figure B). [33] Other cutaneous manifestations include papules, nodules, plaques on the face and lips, and verrucous and hyperkeratotic lesions at sites of trauma or friction. [29] Early clinical clues, namely cutaneous buttocks lesions, may predict a more severe clinical course with neurologic involvement. [34] There have been infrequent reports of patchy or diffuse alopecia at lesional sites."}
{"id": "article-129466_12", "title": "Lipoid Proteinosis -- History and Physical", "content": "Other notable features of LP reflect the infiltrating hyaline-like material throughout the mouth and upper aerodigestive tract. Cobblestone appearance of the oral mucosa, yellow lip nodules, lip eversion, and vegetative lesions and fissures at the lateral commissures can be seen in patients with extensive disease. [6] [29] [31]", "contents": "Lipoid Proteinosis -- History and Physical. Other notable features of LP reflect the infiltrating hyaline-like material throughout the mouth and upper aerodigestive tract. Cobblestone appearance of the oral mucosa, yellow lip nodules, lip eversion, and vegetative lesions and fissures at the lateral commissures can be seen in patients with extensive disease. [6] [29] [31]"}
{"id": "article-129466_13", "title": "Lipoid Proteinosis -- History and Physical", "content": "As a result of deposits obstructing Stenson\u2019s duct and secondary xerostomia, patients with LP are prone to frequent upper respiratory tract infections, recurrent parotitis, and dental caries.\u00a0The submandibular gland can become similarly obstructed and inflamed. [10] The tongue is often \u201cwoody\u201d to palpation, with absent dorsal papillae, a shortened and thickened frenulum, and restricted protrusion. [6] [35]", "contents": "Lipoid Proteinosis -- History and Physical. As a result of deposits obstructing Stenson\u2019s duct and secondary xerostomia, patients with LP are prone to frequent upper respiratory tract infections, recurrent parotitis, and dental caries.\u00a0The submandibular gland can become similarly obstructed and inflamed. [10] The tongue is often \u201cwoody\u201d to palpation, with absent dorsal papillae, a shortened and thickened frenulum, and restricted protrusion. [6] [35]"}
{"id": "article-129466_14", "title": "Lipoid Proteinosis -- History and Physical", "content": "Neurologic manifestations of LP can be severe, including epilepsy, dystonia, progressive neuropsychiatric disorders (memory loss and other cognitive impairment, behavioral changes, hallucination, schizophreniform illness), and spontaneous central nervous system (CNS) hemorrhage. [3] [36] Hyaline-like material can be deposited throughout the CNS with or without consequent symptomatology. [37] A post-mortem neuropathologic analysis showed calcium accumulation with evidence of adjacent gliosis, vessel calcification, and occlusions with perivascular infarctions, and demyelination. [37]", "contents": "Lipoid Proteinosis -- History and Physical. Neurologic manifestations of LP can be severe, including epilepsy, dystonia, progressive neuropsychiatric disorders (memory loss and other cognitive impairment, behavioral changes, hallucination, schizophreniform illness), and spontaneous central nervous system (CNS) hemorrhage. [3] [36] Hyaline-like material can be deposited throughout the CNS with or without consequent symptomatology. [37] A post-mortem neuropathologic analysis showed calcium accumulation with evidence of adjacent gliosis, vessel calcification, and occlusions with perivascular infarctions, and demyelination. [37]"}
{"id": "article-129466_15", "title": "Lipoid Proteinosis -- History and Physical", "content": "Bilateral, symmetric comma-shaped calcification of the amygdala is a pathognomonic radiologic finding. Calcification has also been reported in the hippocampus, basal ganglia, parahippocampal gyrus, uncinate gyrus, striatum, pineal gland, and perirhinal and parietal cortices. [37] [38] [39] Calcifications develop slowly and are therefore seen more frequently in patients greater than age 10 and in those with longer disease duration. [37] [40]", "contents": "Lipoid Proteinosis -- History and Physical. Bilateral, symmetric comma-shaped calcification of the amygdala is a pathognomonic radiologic finding. Calcification has also been reported in the hippocampus, basal ganglia, parahippocampal gyrus, uncinate gyrus, striatum, pineal gland, and perirhinal and parietal cortices. [37] [38] [39] Calcifications develop slowly and are therefore seen more frequently in patients greater than age 10 and in those with longer disease duration. [37] [40]"}
{"id": "article-129466_16", "title": "Lipoid Proteinosis -- History and Physical", "content": "One study of 10 patients with LP radiographically identified six with amygdaloid complex calcification and degeneration and three with decreased perfusion to the medial temporal lobe, suspicious for underlying calcification.\u00a0Though these nine patients did not differ from healthy controls for cognitive tasks (memory, attention, executive function), they differed from recognizing facial expression, emotional processing, and odor-associative learning and recognition. [39] In an analysis of 7 patients with intracranial calcifications, four had epilepsy with onset in childhood or young adulthood. [36]", "contents": "Lipoid Proteinosis -- History and Physical. One study of 10 patients with LP radiographically identified six with amygdaloid complex calcification and degeneration and three with decreased perfusion to the medial temporal lobe, suspicious for underlying calcification.\u00a0Though these nine patients did not differ from healthy controls for cognitive tasks (memory, attention, executive function), they differed from recognizing facial expression, emotional processing, and odor-associative learning and recognition. [39] In an analysis of 7 patients with intracranial calcifications, four had epilepsy with onset in childhood or young adulthood. [36]"}
{"id": "article-129466_17", "title": "Lipoid Proteinosis -- History and Physical", "content": "Focal seizures were the most common subtype, as demonstrated by video electroencephalography. Patients with certain mutations tended to be resistant to anti-epileptic therapy while others attained seizure-control with levetiracetam and clobazam. [36]", "contents": "Lipoid Proteinosis -- History and Physical. Focal seizures were the most common subtype, as demonstrated by video electroencephalography. Patients with certain mutations tended to be resistant to anti-epileptic therapy while others attained seizure-control with levetiracetam and clobazam. [36]"}
{"id": "article-129466_18", "title": "Lipoid Proteinosis -- History and Physical", "content": "Finally, there have been rare reports of hyaline-like deposits throughout the digestive tract, some of which regressed with time. [4] One patient presented with acute gastrointestinal hemorrhage as a result of deposits within the small bowel. [4] [5]", "contents": "Lipoid Proteinosis -- History and Physical. Finally, there have been rare reports of hyaline-like deposits throughout the digestive tract, some of which regressed with time. [4] One patient presented with acute gastrointestinal hemorrhage as a result of deposits within the small bowel. [4] [5]"}
{"id": "article-129466_19", "title": "Lipoid Proteinosis -- Evaluation", "content": "Because of its autosomal recessive inheritance pattern, patients with LP should be asked about family members with similar symptoms and consanguinity. Synthesis of family history, clinical exam, and histopathologic findings often raise suspicion for LP, though definitive diagnosis can only be made upon identifying an ECM1 mutation.", "contents": "Lipoid Proteinosis -- Evaluation. Because of its autosomal recessive inheritance pattern, patients with LP should be asked about family members with similar symptoms and consanguinity. Synthesis of family history, clinical exam, and histopathologic findings often raise suspicion for LP, though definitive diagnosis can only be made upon identifying an ECM1 mutation."}
{"id": "article-129466_20", "title": "Lipoid Proteinosis -- Evaluation", "content": "An otolaryngologist should evaluate patients to assess airway involvement and identify any degree of obstruction. Similarly, patients with neurologic or neuropsychiatric symptoms merit evaluation and follow-up with a neurologist and psychiatrist. Neuroimaging may become necessary to identify involved brain regions. Other evaluations will depend on disease manifestations but should include frequent dental, dermatologic, and ophthalmic evaluation.", "contents": "Lipoid Proteinosis -- Evaluation. An otolaryngologist should evaluate patients to assess airway involvement and identify any degree of obstruction. Similarly, patients with neurologic or neuropsychiatric symptoms merit evaluation and follow-up with a neurologist and psychiatrist. Neuroimaging may become necessary to identify involved brain regions. Other evaluations will depend on disease manifestations but should include frequent dental, dermatologic, and ophthalmic evaluation."}
{"id": "article-129466_21", "title": "Lipoid Proteinosis -- Treatment / Management", "content": "There are been no randomized trials to establish a standard of care for LP. Treatment plans should be individualized based on manifestations of disease and desire for improved cosmetic outcomes.", "contents": "Lipoid Proteinosis -- Treatment / Management. There are been no randomized trials to establish a standard of care for LP. Treatment plans should be individualized based on manifestations of disease and desire for improved cosmetic outcomes."}
{"id": "article-129466_22", "title": "Lipoid Proteinosis -- Treatment / Management", "content": "Systemic retinoids such as acitretin or etretinate may be effective in treating cutaneous and laryngeal lesions by decreasing the amount of hyaline-like deposits within the dermis. [41] Case reports describing long-term acitretin therapy (0.5mg/kg per day) have noted healing of ulcerated and vesicobullous lesions decrease in tongue size with an improved protrusion, [42] diminished hoarseness\u00a0and softening of hyperkeratotic verrucous papules and nodules. [43] A few patients who saw improved voice quality had limited, if any, cutaneous improvement. [44] [45]", "contents": "Lipoid Proteinosis -- Treatment / Management. Systemic retinoids such as acitretin or etretinate may be effective in treating cutaneous and laryngeal lesions by decreasing the amount of hyaline-like deposits within the dermis. [41] Case reports describing long-term acitretin therapy (0.5mg/kg per day) have noted healing of ulcerated and vesicobullous lesions decrease in tongue size with an improved protrusion, [42] diminished hoarseness\u00a0and softening of hyperkeratotic verrucous papules and nodules. [43] A few patients who saw improved voice quality had limited, if any, cutaneous improvement. [44] [45]"}
{"id": "article-129466_23", "title": "Lipoid Proteinosis -- Treatment / Management", "content": "There is conflicting evidence about the efficacy of long-term oral dimethyl sulfoxide (DMSO) for the treatment of cutaneous lesions and hoarseness. [46] [47] One case report noted clinical improvement with the chelating agent D-penicillamine 600mg/day. [48]", "contents": "Lipoid Proteinosis -- Treatment / Management. There is conflicting evidence about the efficacy of long-term oral dimethyl sulfoxide (DMSO) for the treatment of cutaneous lesions and hoarseness. [46] [47] One case report noted clinical improvement with the chelating agent D-penicillamine 600mg/day. [48]"}
{"id": "article-129466_24", "title": "Lipoid Proteinosis -- Treatment / Management", "content": "For patients with vocal cord involvement and impaired phonation, microlaryngoscopy and carbon dioxide (CO) laser procedures can be quite successful. [49] [50] However, there is a risk of postoperative granulation tissue formation, fibrosis, and the need for follow-up interventions.\u00a0For this reason, some argue that surgical intervention is only indicated with a compromised airway.", "contents": "Lipoid Proteinosis -- Treatment / Management. For patients with vocal cord involvement and impaired phonation, microlaryngoscopy and carbon dioxide (CO) laser procedures can be quite successful. [49] [50] However, there is a risk of postoperative granulation tissue formation, fibrosis, and the need for follow-up interventions.\u00a0For this reason, some argue that surgical intervention is only indicated with a compromised airway."}
{"id": "article-129466_25", "title": "Lipoid Proteinosis -- Treatment / Management", "content": "To minimize the appearance of scars and moniliform blepharosis, cosmetic procedures such as CO laser, dermabrasion, blepharoplasty, and erbium-doped yttrium aluminum garnet ablative laser have been employed. [51] [52] [53]", "contents": "Lipoid Proteinosis -- Treatment / Management. To minimize the appearance of scars and moniliform blepharosis, cosmetic procedures such as CO laser, dermabrasion, blepharoplasty, and erbium-doped yttrium aluminum garnet ablative laser have been employed. [51] [52] [53]"}
{"id": "article-129466_26", "title": "Lipoid Proteinosis -- Treatment / Management", "content": "Management of neurologic and psychiatric manifestations of LP should be tailored to each individual. Certain anti-epileptic medications can minimize seizure frequency and severity. Anti-psychotic medication can help manage behavioral changes and psychosis.", "contents": "Lipoid Proteinosis -- Treatment / Management. Management of neurologic and psychiatric manifestations of LP should be tailored to each individual. Certain anti-epileptic medications can minimize seizure frequency and severity. Anti-psychotic medication can help manage behavioral changes and psychosis."}
{"id": "article-129466_27", "title": "Lipoid Proteinosis -- Differential Diagnosis", "content": "Differential diagnoses may differ between patients. Possible differential diagnoses include:", "contents": "Lipoid Proteinosis -- Differential Diagnosis. Differential diagnoses may differ between patients. Possible differential diagnoses include:"}
{"id": "article-129466_28", "title": "Lipoid Proteinosis -- Differential Diagnosis -- Cutaneous lesions:", "content": "Herpes simplex infection Impetigo Epidermolysis bullosa Erythropoietic protoporphyria Lichen myxedematosus Systemic amyloidosis Nodular localized cutaneous amyloidosis Colloid milium Hyalinosis Xanthomas Scleromyxedema Leprosy Hydroa vacciniforme Incontinentia pigmenti", "contents": "Lipoid Proteinosis -- Differential Diagnosis -- Cutaneous lesions:. Herpes simplex infection Impetigo Epidermolysis bullosa Erythropoietic protoporphyria Lichen myxedematosus Systemic amyloidosis Nodular localized cutaneous amyloidosis Colloid milium Hyalinosis Xanthomas Scleromyxedema Leprosy Hydroa vacciniforme Incontinentia pigmenti"}
{"id": "article-129466_29", "title": "Lipoid Proteinosis -- Differential Diagnosis -- Hoarseness:", "content": "Laryngitis Laryngotracheitis Laryngotracheobronchitis Vocal cord nodules Gastroesophageal reflux disease Vocal cord polyps Laryngeal hemangiomas Laryngeal cysts Vocal cord paralysis Vocal cord hypertrophy", "contents": "Lipoid Proteinosis -- Differential Diagnosis -- Hoarseness:. Laryngitis Laryngotracheitis Laryngotracheobronchitis Vocal cord nodules Gastroesophageal reflux disease Vocal cord polyps Laryngeal hemangiomas Laryngeal cysts Vocal cord paralysis Vocal cord hypertrophy"}
{"id": "article-129466_30", "title": "Lipoid Proteinosis -- Differential Diagnosis -- Enlarged tongue:", "content": "Systemic amyloidosis Hypothyroidism (congenital) Myxedema Acromegaly", "contents": "Lipoid Proteinosis -- Differential Diagnosis -- Enlarged tongue:. Systemic amyloidosis Hypothyroidism (congenital) Myxedema Acromegaly"}
{"id": "article-129466_31", "title": "Lipoid Proteinosis -- Differential Diagnosis -- Mesial temporal lobe calcification:", "content": "Fahr\u2019s disease Calcified glioma Raine syndrome Healed herpes encephalitis Dystonia", "contents": "Lipoid Proteinosis -- Differential Diagnosis -- Mesial temporal lobe calcification:. Fahr\u2019s disease Calcified glioma Raine syndrome Healed herpes encephalitis Dystonia"}
{"id": "article-129466_32", "title": "Lipoid Proteinosis -- Prognosis", "content": "LP typically runs a benign but progressive course that is compatible with a normal lifespan. Respiratory obstruction and central nervous system involvement, however, can be life-threatening or impart significant morbidity.", "contents": "Lipoid Proteinosis -- Prognosis. LP typically runs a benign but progressive course that is compatible with a normal lifespan. Respiratory obstruction and central nervous system involvement, however, can be life-threatening or impart significant morbidity."}
{"id": "article-129466_33", "title": "Lipoid Proteinosis -- Complications", "content": "LP can cause a wide variety of clinical manifestations due to hyaline deposition in the skin, mucosa, and various organs. Of the possible clinical complications, airway obstruction, seizures, spontaneous CNS hemorrhage are the most severe. Hyaline deposition within the small bowel has also been linked to cases of gastrointestinal bleeding. [4] [5]", "contents": "Lipoid Proteinosis -- Complications. LP can cause a wide variety of clinical manifestations due to hyaline deposition in the skin, mucosa, and various organs. Of the possible clinical complications, airway obstruction, seizures, spontaneous CNS hemorrhage are the most severe. Hyaline deposition within the small bowel has also been linked to cases of gastrointestinal bleeding. [4] [5]"}
{"id": "article-129466_34", "title": "Lipoid Proteinosis -- Complications", "content": "There can also be complications as a result of surgical intervention on the vocal cords or larynx. These include bleeding, infection, and vocal cord scarring leading to a change in voice quality and a possible need for repeat intervention.", "contents": "Lipoid Proteinosis -- Complications. There can also be complications as a result of surgical intervention on the vocal cords or larynx. These include bleeding, infection, and vocal cord scarring leading to a change in voice quality and a possible need for repeat intervention."}
{"id": "article-129466_35", "title": "Lipoid Proteinosis -- Complications", "content": "Finally, certain patients may be taking systemic medication to manage their disease, such as anti-psychotic, anti-epileptic, and dopamine-modifying agents. These medications can have a variety of drug-specific side effects.", "contents": "Lipoid Proteinosis -- Complications. Finally, certain patients may be taking systemic medication to manage their disease, such as anti-psychotic, anti-epileptic, and dopamine-modifying agents. These medications can have a variety of drug-specific side effects."}
{"id": "article-129466_36", "title": "Lipoid Proteinosis -- Consultations", "content": "A multidisciplinary approach is recommended for patients with LP. Counseling may involve a dermatologist, otolaryngologist, neurologist, psychiatrist, dentist, and geneticist depending on manifestations of the disease. Like other autosomal recessive conditions, carrier testing and reproductive counseling should be offered to patients and their family members.", "contents": "Lipoid Proteinosis -- Consultations. A multidisciplinary approach is recommended for patients with LP. Counseling may involve a dermatologist, otolaryngologist, neurologist, psychiatrist, dentist, and geneticist depending on manifestations of the disease. Like other autosomal recessive conditions, carrier testing and reproductive counseling should be offered to patients and their family members."}
{"id": "article-129466_37", "title": "Lipoid Proteinosis -- Enhancing Healthcare Team Outcomes", "content": "LP is a rare genetic disease that requires interprofessional collaboration for optimal patient care. Patients with suspected LP should undergo a comprehensive workup with several specialists, including a dermatologist, neurologist, psychiatrist, otolaryngologist, dentist, and geneticist. It is important to assess disease burden and to evaluate for any possibly life-threatening manifestations. Patients\u2019 symptoms and quality of life should be assessed frequently. Additionally, genetic counseling may offer patients a better understanding of their condition and its mode of inheritance.", "contents": "Lipoid Proteinosis -- Enhancing Healthcare Team Outcomes. LP is a rare genetic disease that requires interprofessional collaboration for optimal patient care. Patients with suspected LP should undergo a comprehensive workup with several specialists, including a dermatologist, neurologist, psychiatrist, otolaryngologist, dentist, and geneticist. It is important to assess disease burden and to evaluate for any possibly life-threatening manifestations. Patients\u2019 symptoms and quality of life should be assessed frequently. Additionally, genetic counseling may offer patients a better understanding of their condition and its mode of inheritance."}
{"id": "article-129466_38", "title": "Lipoid Proteinosis -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Lipoid Proteinosis -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}